DHR vs QCOM: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and QUALCOMM Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
QUALCOMM Incorporated · Technology
$134.47
+77.7% upside to fair value
Med Conviction Grade B
QuantHub Verdict
QCOM has more upside to fair value (+77.7%). QCOM trades at a lower forward P/E (26.8x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric DHR QCOM
Current Price $174.04 $134.47
Fair Value Estimate $197.01 $239.00
Upside to Fair Value +13.2% +77.7%
Market Cap $123.2B $143.6B
Forward P/E 33.4x 26.8x
EV / EBITDA 20.3x
Price / Sales 5.0x 3.2x
Price / FCF 23.3x 11.1x
Revenue Growth YoY +3.7% +8.7%
Gross Margin 60.7% 55.1%
Operating Margin 21.0% 27.1%
Return on Equity 7.1% 21.6%
Dividend Yield 0%
FCF Yield 4.3% 9.0%
Analyst Consensus Strong Buy Hold
Investment Thesis
DHR — Danaher Corporation
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
QCOM — QUALCOMM Incorporated
Qualcomm Incorporated is a leading semiconductor company specializing in wireless chipsets and IP licensing, with dominant positions in 5G modems via QCT (87% of revenue) and steady QTL royalties. The business excels through a vast patent moat, diversification into automotive and IoT, and robust growth (revenue +13% YoY to $44B in FY2025), but faces risks from Apple modem shifts and China exposur…
Accumulation Zones
Metric DHR QCOM
Zone Low $147.76 $179.00
Zone High $167.46 $203.00
In Buy Zone? No Yes
← DHR Research    QCOM Research →    All Research